HIT Consultant October 29, 2025
What You Should Know:
– Curve Biosciences, the Whole-Body Intelligence™ company, today announced it has raised $40M in Series A funding led by Luma Group, with participation from First Spark Ventures, Techas Capital, Civilization Ventures, LifeX Ventures, and others.
– The funding will be used to accelerate the clinical validation and commercialization of its platform for chronic disease monitoring.
Molecular Blueprint for Chronic Disease
Curve Biosciences is addressing the rising costs and increasing prevalence of chronic diseases, asserting that improvements in patient monitoring are necessary to realize the full positive impact of modern breakthroughs, such as GLP-1s.
The company has developed the Whole-Body Atlas™, which is described as the world’s largest collection of manually curated tissue samples characterized...
Today's Sponsors
Today's Sponsor